These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8784061)

  • 1. Are allelic losses at 11q13 universal in MEN 1 tumors?
    Brandi ML; Falchetti A; Tonelli F; Bordi C
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3162-3. PubMed ID: 8784061
    [No Abstract]   [Full Text] [Related]  

  • 2. A possible tumor suppressor gene for parathyroid adenomas.
    Iwasaki H
    Int Surg; 1996; 81(1):71-6. PubMed ID: 8803711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors.
    Hessman O; Lindberg D; Einarsson A; Lillhager P; Carling T; Grimelius L; Eriksson B; Akerström G; Westin G; Skogseid B
    Genes Chromosomes Cancer; 1999 Nov; 26(3):258-64. PubMed ID: 10502325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss in parathyroid tumors from individuals homozygous for multiple endocrine neoplasia type 1.
    Falchetti A; Morelli A; Amorosi A; Tonelli F; Fabiani S; Martineti V; Castello R; Furlani L; Brandi ML
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2278-82. PubMed ID: 9215307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1.
    Dong Q; Debelenko LV; Chandrasekharappa SC; Emmert-Buck MR; Zhuang Z; Guru SC; Manickam P; Skarulis M; Lubensky IA; Liotta LA; Collins FS; Marx SJ; Spiegel AM
    J Clin Endocrinol Metab; 1997 May; 82(5):1416-20. PubMed ID: 9141526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia type 1 and the search for the genetic trigger.
    Farnebo F; Järhult J; Farnebo LO; Nilsson O; Teh BT; Lagercrantz J; Weber G; Sandelin K; Larsson C
    Horm Res; 1997; 47(4-6):179-84. PubMed ID: 9167950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis.
    Emmert-Buck MR; Lubensky IA; Dong Q; Manickam P; Guru SC; Kester MB; Olufemi SE; Agarwal S; Burns AL; Spiegel AM; Collins FS; Marx SJ; Zhuang Z; Liotta LA; Chandrasekharappa SC; Debelenko LV
    Cancer Res; 1997 May; 57(10):1855-8. PubMed ID: 9157974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
    Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
    Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of the tumor suppressor gene on 11q13 in brothers with familial acrogigantism without multiple endocrine neoplasia type 1.
    Yamada S; Yoshimoto K; Sano T; Takada K; Itakura M; Usui M; Teramoto A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):239-42. PubMed ID: 8989266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal analysis by chromosome 11 microsatellite-PCR of microdissected parathyroid tumors from MEN 1 patients.
    Morelli A; Falchetti A; Amorosi A; Tonelli F; Bearzi I; Ranaldi R; Tomassetti P; Brandi ML
    Biochem Biophys Res Commun; 1996 Oct; 227(3):736-42. PubMed ID: 8886003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors.
    Hessman O; Skogseid B; Westin G; Akerström G
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1355-61. PubMed ID: 11238532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas.
    Tanaka C; Kimura T; Yang P; Moritani M; Yamaoka T; Yamada S; Sano T; Yoshimoto K; Itakura M
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2631-4. PubMed ID: 9709923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients.
    Lubensky IA; Debelenko LV; Zhuang Z; Emmert-Buck MR; Dong Q; Chandrasekharappa S; Guru SC; Manickam P; Olufemi SE; Marx SJ; Spiegel AM; Collins FS; Liotta LA
    Cancer Res; 1996 Nov; 56(22):5272-8. PubMed ID: 8912868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human HNP36 gene is localized to chromosome 11q13 and produces alternative transcripts that are not mutated in multiple endocrine neoplasia, type 1 (MEN I) syndrome.
    Williams JB; Rexer B; Sirripurapu S; John S; Goldstein R; Phillips JA; Haley LL; Sait SN; Shows TB; Smith CM; Gerhard DS
    Genomics; 1997 Jun; 42(2):325-30. PubMed ID: 9192854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11q13 allelotype analysis in 27 northern American MEN1 kindreds identifies two distinct founder chromosomes.
    Emmert-Buck MR; Debelenko LV; Agarwal S; Kester MB; Manickam P; Zhuang Z; Guru SC; Olufemi SE; Burns AL; Chandrasekharappa SC; Lubensky IA; Liotta LA; Skarulis MC; Spiegel AM; Marx SJ; Collins FS
    Mol Genet Metab; 1998 Feb; 63(2):151-5. PubMed ID: 9562970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.
    Kjellman M; Roshani L; Teh BT; Kallioniemi OP; Höög A; Gray S; Farnebo LO; Holst M; Bäckdahl M; Larsson C
    J Clin Endocrinol Metab; 1999 Feb; 84(2):730-5. PubMed ID: 10022445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Familial pituitary tumors].
    Yoshimoto K; Saito S
    Nihon Rinsho; 1995 Nov; 53(11):2691-6. PubMed ID: 8538028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
    Guo SS; Wu AY; Sawicki MP
    World J Surg; 2002 Jul; 26(7):843-7. PubMed ID: 11960210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1.
    Friedman E; Sakaguchi K; Bale AE; Falchetti A; Streeten E; Zimering MB; Weinstein LS; McBride WO; Nakamura Y; Brandi ML
    N Engl J Med; 1989 Jul; 321(4):213-8. PubMed ID: 2568586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.